Hot Topics
- Prostate cancer
- Bladder cancer
- Renal cancer
- Urinary incontinence and overactive bladder
- Endourology
- New BPH procedures
- Assessment and approval of new technology
Friday, November 9, 2018
(each session will include 25% of its time for interactivity btw audience and session presenters)
| 0700 |
Registration Continental Breakfast with exhibitors |
| 0755 | Welcome Dr. Sender Herschorn |
Localized Prostate Cancer
|
|
| 0800 | Debate: MRI should become part of the standard of care prior to biopsy for prostate cancer
|
| 0830 | Risk calculators for prostate cancer prediction and prognosis: Are we any further ahead? Dr. Robert Nam |
| 0840 | In whom should I reconsider active surveillance? Use of ancillary testing and genomics for risk stratification. Dr. Neil Fleshner |
| 0850 | Discussion with audience |
| 0900 | Vincent Colapinto Memorial Lecture The role of lifestyle, diet and cholesterol metabolism in prostate cancer development and progression: implications for practicing urologists Dr. Stephen Freedland |
| 0920 | Discussion |
| 0930 | Break with exhibitors |
Kidney Cancer
|
|
| 1000 | Debate: Biopsy should be the standard of care for all small renal masses
|
| 1030 | Debate: Renal ischemia is of paramount importance when performing partial nephrectomy
|
| 1100 | Cytoreductive nephrectomy: when and in whom? Dr. Steven Boorjian |
| 1115 | Adjuvant chemotherapy in RCC: should I be referring my patients? Dr. Alexander Kutikov |
| 1130 | Discussion audience |
| 1145 | Lunch with exhibitors |
Health technology assessment of Robotic Surgery – Views from different provinces
|
|
| 1230 | The Ontario assessment of robotic surgery Dr. Irfan Dhalla |
| 1255 | The Alberta assessment of robotic surgery Dr. Devidas Menon |
| 1320 | Panel discussion: Robotic surgery and other new technologies Drs. Iran Dhalla, Devidas Menon, Murray Krahn, Neil Fleshner |
Bladder Cancer
|
|
| 1400 | Robotic Cystectomy: the RAZOR trial and its implications for clinical practice Dr. Dipen Parekh |
| 1415 | The emerging role of precision medicine in Bladder Cancer Dr. Alexandre Zlotta |
| 1430 | Chemotherapy for Upper Tract Urothelial Carcinoma: When should I be referring my patients? Dr. Girish Kulkarni |
| 1445 | Urothelial carcinoma case based discussion PANEL: Drs. Zlotta, Parekh, Fleshner |
| 1500 | Break with exhibitors |
Advanced Prostate Cancer
|
|
| 1530 | Androgen Targeted Therapy in Prostate Cancer: A clinically relevant update for 2018 Dr. Laurence Klotz |
| 1545 | A Canadian perspective on PSMA PET imaging in prostate cancer: implications for the M0CRPC state Dr. Robert Hamilton |
| 1600 | In whom should we be offering oligometastectomy in prostate cancer? Dr. Steven Boorjian |
| 1615 | Treatment of the primary tumour in metastatic prostate cancer: are we ready for cytoreductive prostate therapy? Dr. Stephen Freedland |
| 1630 | Prostate cancer case-based discussion PANEL: Drs. Klotz, Hamilton, Freedland, Boorjian |
| 1700 | Adjourn |
Saturday, November 10, 2018
(each session will include 25% of its time for interactivity btw audience and session presenters)
| 0715 |
Registration Continental breakfast with exhibitors |
Endourology
|
|
| 0800 | A practical approach to stone metabolics Dr. Martin Schreiber |
| 0820 | Discussion with audience |
| 0825 | Debate: Who needs a 24h urine metabolic workup in 2018?
|
What’s new in Endourology? |
|
| 0855 | New technologies for ureteroscopy Dr. Monica Farcas |
| 0907 | Tips for minimizing radiation exposure in Endourology Dr. Mitchell Humphreys |
| 0919 | Shock wave lithotripsy: Alive and kicking in 2018! Dr. Kenneth Pace |
| 0931 | When should we dust? When should we fragment? Dr. Michael Ordon |
| 0943 | Discussion with audience |
| 1000 | Break with exhibitors |
Endourology
|
|
| 1020 | The intermediate sized renal stone: Case-based discussion
|
Practical tips for the practicing urologist: Case-based discussions |
|
| 1050 |
|
Incontinence and OAB
|
|
Case of primary SUI in women |
|
| 1120 | Evidenced-based workup for SUI Dr. Kathleen Kobashi |
| 1135 | Status of non-invasive options – bulking agents and vaginal laser procedures Dr. Lesley Carr |
| 1145 | Non-mesh versus mesh repairs for primary surgery – which is better? Dr. Dan Elliott |
| 1200 | How I manage complications and bad outcomes of SUI surgery
|
| 1220 | Lunch with exhibitors |
Postprostatectomy incontinence
|
|
| 1305 | Is there an evidence-based workup? Dr. Sidney Radomski |
| 1315 | Indications and evidence for slings. Dr. Sender Herschorn |
| 1330 | The artificial sphincter – current status Dr. Dan Elliott |
| 1345 | Cases of post-prostatectomy incontinence Panel discussion and questions |
OAB – difficult problems in management
|
|
| 1400 | What is the right way to manage mixed incontinence in women? Dr. Kathleen Kobashi |
| 1410 | Management of OAB in men with BPH/LUTS Dr. Sidney Radomski |
| 1420 | Evidence for third-line therapy and why is it underused? Dr. Lesley Carr |
| 1430 | Do urologists have to worry about anticholinergic burden in elderly OAB patients? Dr. Sender Herschorn |
| 1440 | Case discussion with audience |
| 1505 | Break with exhibitors |
New BPH procedures
|
|
| 1530 | Case of man with BPO and failed medical therapy Dr. S. RadomskiDebate: optimal surgical procedure for 80 gm prostate; 150 gm prostate; anticoagulation |
| 1535 | Transurethral enucleation Dr. Naeem Bhojani |
| 1545 | TURP or plasma button Dr. Sid Radomski |
| 1555 | Greenlight laser Dr. Dean Elterman |
| 1605 | Rebuttal |
Emerging technologies for BPH |
|
| 1610 | Aquablation Dr. Naeem Bhojani |
| 1620 | Urolift and embolization Dr. Dean Elterman |
| 1630 | Rezum Dr. Naeem Bhojani |
| 1640 | Case discussion with audience |
| 1700 | Adjourn |